Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 22Prostatic Neoplasms 11Osteoporosis 8Vitamin D Deficiency 7Polycystic Ovary Syndrome 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Colonic Neoplasms 5Obesity 3Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Inflammation 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Bone Diseases, Metabolic 3Multiple Endocrine Neoplasia Type 1 2Motor Activity 2Lymphoma 2Leukemia 2Leiomyoma 2Giant Cell Tumor of Bone 2Gastrointestinal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Bone Diseases 2Warts 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

aldesleukin 42Sunitinib 39Cyclophosphamide 30Nivolumab 27Everolimus 27pembrolizumab 26Interferon-alpha 25Bevacizumab 22Sorafenib 21Interleukin-2 20fludarabine phosphate 19Filgrastim 18Ipilimumab 17Radiotherapy 16Axitinib 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14fludarabine 11Radiosurgery 11Doxorubicin 11Carboplatin 11temsirolimus 10Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8belzutifan 8atezolizumab 8Fluorouracil 8pazopanib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Kidney Neoplasms × Vitamin D × Clear all
NCT03520231 2021-11-23

Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

University Health Network, Toronto

Phase 2 Completed
6 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Kidney Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡